Search Results 2341-2350 of 40536 for Two-phase

  1. Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  3. Wet macular degeneration - Symptoms and causes - Mayo Clinic

    Wet macular degeneration is one of two types of age-related macular degeneration. The other type, dry macular degeneration, is more common and less severe ...

  4. A Study to Compare Three Chemotherapy Regimens for the Treatment of Patients with Newly- diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Impetigo - Diagnosis & treatment - Mayo Clinic

    Treatment. Impetigo is treated with prescription mupirocin antibiotic ointment or cream applied directly to the sores two to three times a day for five ...

  6. Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. Neurology - Clinical trials

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  8. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Childhood apraxia of speech - Symptoms and causes - Mayo Clinic

    2 can raise the risk of speech sound disorders, including CAS. CAS also can be part of certain genetic syndromes that affect the whole body. One example is ...